Detailed transcription map of Aleutian mink disease parvovirus.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMC 253511)

Published in J Virol on October 01, 1988

Authors

S Alexandersen1, M E Bloom, S Perryman

Author Affiliations

1: National Institute of Allergy and Infectious Diseases, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840.

Articles citing this

Parvovirus replication. Microbiol Rev (1990) 3.37

The minor capsid protein VP1 of the autonomous parvovirus minute virus of mice is dispensable for encapsidation of progeny single-stranded DNA but is required for infectivity. J Virol (1993) 1.67

Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol (1993) 1.42

The transcription profile of Aleutian mink disease virus in CRFK cells is generated by alternative processing of pre-mRNAs produced from a single promoter. J Virol (2006) 1.41

Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity. J Virol (1999) 1.27

The transcription profile of the bocavirus bovine parvovirus is unlike those of previously characterized parvoviruses. J Virol (2007) 1.24

Analysis of experimental mink enteritis virus infection in mink: in situ hybridization, serology, and histopathology. J Virol (1990) 1.22

Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. J Virol (1991) 1.21

Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system. J Virol (1993) 1.19

Comparison of promoter activity in Aleutian mink disease parvovirus, minute virus of mice, and canine parvovirus: possible role of weak promoters in the pathogenesis of Aleutian mink disease parvovirus infection. J Virol (1993) 1.17

Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J Virol (1991) 1.13

Characterization of early pathogenic effects after experimental infection of calves with bovine immunodeficiency-like virus. J Virol (1992) 1.11

The relationship between capsid protein (VP2) sequence and pathogenicity of Aleutian mink disease parvovirus (ADV): a possible role for raccoons in the transmission of ADV infections. J Virol (1996) 1.10

Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection. J Virol (1993) 1.09

Nucleotide sequence of the 5'-terminal palindrome of Aleutian mink disease parvovirus and construction of an infectious molecular clone. J Virol (1990) 1.08

SAT: a late NS protein of porcine parvovirus. J Virol (2005) 1.08

Purification and characterization of the major nonstructural protein (NS-1) of Aleutian mink disease parvovirus. J Virol (1995) 1.05

cis-acting sequences in the Aleutian mink disease parvovirus late promoter important for transcription: comparison to the canine parvovirus and minute virus of mice. J Virol (1993) 1.05

Characterization of chimeric full-length molecular clones of Aleutian mink disease parvovirus (ADV): identification of a determinant governing replication of ADV in cell culture. J Virol (1993) 1.03

Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation. J Virol (2001) 1.03

Subcellular localization of Aleutian mink disease parvovirus proteins and DNA during permissive infection of Crandell feline kidney cells. J Virol (1996) 1.03

Identification and characterization of two internal cleavage and polyadenylation sites of parvovirus B19 RNA. J Virol (2006) 1.00

Proteins of viral and cellular origin bind to the Aleutian disease virus (ADV) DNA 3'-terminal hairpin: presentation of a scheme for encapsidation of ADV DNA. J Virol (1990) 1.00

Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions. J Virol (1997) 0.99

S-phase-dependent cell cycle disturbances caused by Aleutian mink disease parvovirus. J Virol (1997) 0.99

Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink. J Virol (1991) 0.98

Identification of Aleutian mink disease parvovirus transcripts in macrophages of infected adult mink. J Virol (1992) 0.98

Expression of Aleutian mink disease parvovirus capsid proteins by a recombinant vaccinia virus: self-assembly of capsid proteins into particles. J Virol (1992) 0.97

Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines. J Virol (1993) 0.96

Pathogenesis of Aleutian mink disease parvovirus infection: effects of suppression of antibody response on viral mRNA levels and on development of acute disease. J Virol (1994) 0.86

Two parvoviruses that cause different diseases in mink have different transcription patterns: transcription analysis of mink enteritis virus and Aleutian mink disease parvovirus in the same cell line. J Virol (1997) 0.86

Role of alveolar type II cells and of surfactant-associated protein C mRNA levels in the pathogenesis of respiratory distress in mink kits infected with Aleutian mink disease parvovirus. J Virol (1994) 0.85

Molecular cloning and expression of key gene encoding hypothetical DNA polymerase from B. mori parvo-like virus. Genet Mol Biol (2010) 0.84

Molecular characterization of the small nonstructural proteins of parvovirus Aleutian mink disease virus (AMDV) during infection. Virology (2014) 0.83

Identification of a cell surface protein from Crandell feline kidney cells that specifically binds Aleutian mink disease parvovirus. J Virol (1999) 0.83

Aleutian disease parvovirus infection of mink and ferrets elicits an antibody response to a second nonstructural viral protein. J Virol (1990) 0.79

Aleutian mink disease virus in free-ranging mink from Sweden. PLoS One (2015) 0.76

Articles cited by this

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

A catalogue of splice junction sequences. Nucleic Acids Res (1982) 39.41

Kinetics of renaturation of DNA. J Mol Biol (1968) 25.41

Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. Microbiol Rev (1983) 24.58

Transcription termination and 3' processing: the end is in site! Cell (1985) 17.46

Enhancer elements. Cell (1983) 10.41

Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol (1983) 7.52

The autonomously replicating parvoviruses of vertebrates. Adv Virus Res (1987) 5.80

Requirement of a downstream sequence for generation of a poly(A) addition site. Cell (1984) 4.87

The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen. J Exp Med (1969) 3.98

Characteristics and taxonomy of Parvoviridae. Intervirology (1985) 3.70

The genome of minute virus of mice, an autonomous parvovirus, encodes two overlapping transcription units. Nucleic Acids Res (1983) 3.48

Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature (1985) 3.38

Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol Cell Biol (1986) 3.34

Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31

Parvovirus genome: nucleotide sequence of H-1 and mapping of its genes by hybrid-arrested translation. J Virol (1983) 3.00

Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice. J Virol (1983) 2.95

Regulation of protein synthesis in virus-infected animal cells. Adv Virus Res (1986) 2.93

Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro (1974) 2.93

DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain. J Virol (1986) 2.89

trans-Activation of parvovirus P38 promoter by the 76K noncapsid protein. J Virol (1985) 2.83

Organization of nonstructural genes of the autonomous parvovirus minute virus of mice. J Virol (1986) 2.82

Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol (1987) 2.74

The pathogenesis of Aleutian disease of mink. 3. Immune complex arteritis. Am J Pathol (1973) 2.24

A precise map of splice junctions in the mRNAs of minute virus of mice, an autonomous parvovirus. J Virol (1986) 2.11

Characterization of Aleutian disease virus as a parvovirus. J Virol (1980) 2.04

Identification of a nonvirion protein of Aleutian disease virus: mink with Aleutian disease have antibody to both virion and nonvirion proteins. J Virol (1982) 2.02

Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77

Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol (1988) 1.74

Nucleotide sequence and genomic organization of Aleutian mink disease parvovirus (ADV): sequence comparisons between a nonpathogenic and a pathogenic strain of ADV. J Virol (1988) 1.70

Three splicing patterns are used to excise the small intron common to all minute virus of mice RNAs. J Virol (1986) 1.64

In situ molecular hybridization for detection of Aleutian mink disease parvovirus DNA by using strand-specific probes: identification of target cells for viral replication in cell cultures and in mink kits with virus-induced interstitial pneumonia. J Virol (1987) 1.56

Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53

The minute virus of mice P39 transcription unit can encode both capsid proteins. J Virol (1986) 1.53

Aleutian disease: a persistent parvovirus infection of mink with a maximal but ineffective host humoral immune response. Prog Med Virol (1986) 1.47

In vitro identification of a B19 parvovirus promoter. Virology (1987) 1.35

Parvovirus gene regulation. J Gen Virol (1987) 1.35

Physical characteristics in eucaryotic promoters. Nucleic Acids Res (1983) 1.34

Analysis of Aleutian disease of mink parvovirus infection using strand-specific hybridization probes. Intervirology (1987) 1.29

The epizootiology of aleutian disease. Front Biol (1976) 1.29

Acute interstitial pneumonia in mink kits: experimental reproduction of the disease. Vet Pathol (1986) 1.21

Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink. J Virol (1985) 1.21

Epizootiologic studies of Aleutian disease. I. Transplacental transmission of the virus. J Infect Dis (1967) 1.19

Demonstration of non-degraded Aleutian disease virus (ADV) proteins in lung tissue from experimentally infected mink kits. Brief report. Arch Virol (1986) 1.14

Molecular comparisons of in vivo- and in vitro-derived strains of Aleutian disease of mink parvovirus. J Virol (1988) 0.93

A nonstructural protein of feline panleukopenia virus: expression in Escherichia coli and detection of multiple forms in infected cells. J Virol (1987) 0.81

Articles by these authors

Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol (1992) 6.72

Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J Virol (1991) 3.28

Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology (1995) 2.55

Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21

Characterization of Aleutian disease virus as a parvovirus. J Virol (1980) 2.04

Identification of a nonvirion protein of Aleutian disease virus: mink with Aleutian disease have antibody to both virion and nonvirion proteins. J Virol (1982) 2.02

Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus. J Immunol (1975) 1.95

Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J Virol (1996) 1.94

Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol (1988) 1.74

Nucleotide sequence and genomic organization of Aleutian mink disease parvovirus (ADV): sequence comparisons between a nonpathogenic and a pathogenic strain of ADV. J Virol (1988) 1.70

In situ molecular hybridization for detection of Aleutian mink disease parvovirus DNA by using strand-specific probes: identification of target cells for viral replication in cell cultures and in mink kits with virus-induced interstitial pneumonia. J Virol (1987) 1.56

Impaired water excretion in myxedema. Am J Med (1971) 1.53

Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus. Proc Natl Acad Sci U S A (1991) 1.40

Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo. J Virol (1989) 1.32

Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity. J Virol (1999) 1.27

Studies on the sequential development of acute interstitial pneumonia caused by Aleutian disease virus in mink kits. J Virol (1987) 1.26

Analysis of experimental mink enteritis virus infection in mink: in situ hybridization, serology, and histopathology. J Virol (1990) 1.22

Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink. J Virol (1985) 1.21

Monoclonal antibodies against Aleutian disease virus distinguish virus strains and differentiate sites of virus replication from sites of viral antigen sequestration. J Virol (1986) 1.18

Replication of Aleutian mink disease parvovirus in lymphoid tissues of adult mink: involvement of follicular dendritic cells and macrophages. J Virol (1991) 1.17

The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease. J Virol (1991) 1.17

Parvovirus infections in wild carnivores. J Wildl Dis (2001) 1.17

Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J Virol (1991) 1.13

Characterization of the Aleutian disease virus genome and its intracellular forms. J Virol (1983) 1.13

Acute interstitial pneumonia in mink kits inoculated with defined isolates of Aleutian mink disease parvovirus. Vet Pathol (1994) 1.11

Transcription of adenovirus-associated virus RNA in isolated KB cell nuclei. Virology (1978) 1.10

The relationship between capsid protein (VP2) sequence and pathogenicity of Aleutian mink disease parvovirus (ADV): a possible role for raccoons in the transmission of ADV infections. J Virol (1996) 1.10

Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection. J Virol (1993) 1.09

Aleutian disease virus, a parvovirus, is proteolytically degraded during in vivo infection in mink. J Virol (1984) 1.08

Nucleotide sequence of the 5'-terminal palindrome of Aleutian mink disease parvovirus and construction of an infectious molecular clone. J Virol (1990) 1.08

Aleutian mink disease parvovirus in wild riparian carnivores in Spain. J Wildl Dis (2001) 1.06

Characterization of chimeric full-length molecular clones of Aleutian mink disease parvovirus (ADV): identification of a determinant governing replication of ADV in cell culture. J Virol (1993) 1.03

Subcellular localization of Aleutian mink disease parvovirus proteins and DNA during permissive infection of Crandell feline kidney cells. J Virol (1996) 1.03

Analysis of the quantity of antiviral antibodies from mink infected with different Aleutian disease virus strains. Scand J Immunol (1984) 1.03

Sequence comparison of the non-structural genes of four different types of Aleutian mink disease parvovirus indicates an unusual degree of variability. Arch Virol (1994) 1.00

Molecular cloning of the Aleutian disease virus genome: expression of Aleutian disease virus antigens by a recombinant plasmid. J Virol (1983) 0.99

Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink. J Virol (1991) 0.98

Identification of Aleutian mink disease parvovirus transcripts in macrophages of infected adult mink. J Virol (1992) 0.98

Sensitive radioimmune assay for measuring Aleutian disease virus antigen and antibody. J Clin Microbiol (1983) 0.97

Expression of Aleutian mink disease parvovirus capsid proteins by a recombinant vaccinia virus: self-assembly of capsid proteins into particles. J Virol (1992) 0.97

Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines. J Virol (1993) 0.96

Identification of differentially expressed genes in scrapie-infected mouse neuroblastoma cells. Microb Pathog (1995) 0.93

Simultaneous identification of viral proteins and nucleic acids in cells infected with Aleutian mink disease parvovirus. Microb Pathog (1990) 0.92

Hyponatremia in pituitary insufficiency. Metabolism (1969) 0.91

Sequence analysis of the lymphotropic Aleutian disease parvovirus ADV-SL3. Arch Virol (1997) 0.89

Nonsuppurative meningoencephalitis associated with Aleutian mink disease parvovirus infection in ranch mink. J Vet Diagn Invest (2000) 0.89

Aleutian mink disease parvovirus infection of K562 cells is antibody-dependent and is mediated via an Fc(gamma)RII receptor. Arch Virol (1997) 0.87

Insulin-induced posthypoglycemic hyperglycemia as a cause of "brittle" diabetes. Clinical clues and therapeutic implications. Am J Med (1969) 0.87

Replication of Aleutian mink disease parvovirus in vivo is influenced by residues in the VP2 protein. J Virol (1999) 0.87

Electroencephalographic characterization of an adult rat model of radiation-induced cortical dysplasia. Epilepsia (2001) 0.86

Two parvoviruses that cause different diseases in mink have different transcription patterns: transcription analysis of mink enteritis virus and Aleutian mink disease parvovirus in the same cell line. J Virol (1997) 0.86

Expression of Aleutian mink disease parvovirus capsid proteins in a baculovirus expression system for potential diagnostic use. J Vet Diagn Invest (1994) 0.86

Interstitial nephritis in Aleutian mink disease. Possible role of cell-mediated immunity against virus-infected tubular epithelial cells. Am J Pathol (1994) 0.86

Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus. J Virol (1997) 0.85

A comparison between permissive and restricted infections with Aleutian mink disease parvovirus (ADV): characterization of the viral protein composition at nuclear sites of virus replication. Virus Res (1998) 0.84

Impaired phagocytosis by the mononuclear phagocytic system in sapphire mink affected with Aleutian disease. Proc Soc Exp Biol Med (1990) 0.84

Demonstration of Aleutian disease virus-specific lymphocyte response in mink with progressive Aleutian disease: comparison of sapphire and pastel mink infected with different virus strains. J Immunol (1983) 0.84

Parvovirus infections: features reminiscent of AIDS. Ann N Y Acad Sci (1984) 0.84

Identification of a cell surface protein from Crandell feline kidney cells that specifically binds Aleutian mink disease parvovirus. J Virol (1999) 0.83

Restricted viral antibody specificity in many ferrets infected with the ferret Aleutian disease parvovirus. Brief report. Arch Virol (1987) 0.81

Mink with Aleutian disease have high-affinity antiviral antibodies. Scand J Immunol (1984) 0.80

Analysis of molecularly cloned DNA reveals minor differences among three virus strains of Aleutian disease of mink parvovirus. Brief report. Arch Virol (1987) 0.80

Mink parvoviruses and interferons: in vitro studies. J Virol (1986) 0.79

Production and characterization of new monoclonal antibodies that distinguish subsets of mink lymphoid cells. Hybridoma (1994) 0.78

Effect of a valine residue at codon 352 of the VP2 capsid protein on in vivo replication and pathogenesis of Aleutian disease parvovirus in mink. Am J Vet Res (2001) 0.78

Replication of Aleutian mink disease parvovirus in mink lymph node histocultures. J Gen Virol (2000) 0.77

Pathogenesis of aleutian mink disease parvovirus and similarities to b19 infection. J Vet Med B Infect Dis Vet Public Health (2005) 0.76

Aleutian disease of mink: production of 14C-labeled antiviral antibodies by mink lymphoid cells in vitro. Infect Immun (1976) 0.76

Annual reporting of hospital mortality rates for Medicare patients--racial aspects. J Natl Med Assoc (1992) 0.75

Virus-like particles in buffy coat cells of normal goats and goats infected with progressive pneumonia virus. Am J Vet Res (1975) 0.75

Oculoglandular tularemia in an inner city child. Pediatrics (1973) 0.75